Creyon Bio is a reinventing drug development company that develops oligonucleotide-based medicines (OBMs). It creates gene-centric therapies and drug modalities such as small molecules and antibodies that identify the engineering principles for OBMs to reduce gene expression levels to small interfering ribonucleic acid (RNA) (siRNA) to deoxyribonucleic acid (DNA) and RNA editing systems.